REZUS-IMMUNIZATSIYA BILAN KECHUVCHI HOMILADORLIKNI OLIB BORISHDA ZAMONAVIY PROFILAKTIK VA DAVOLASH YONDASHUVLARINING SAMARADORLIGINI BAHOLASH
Keywords:
rezus-immunizatsiya, anti-D immunoglobulin, alloimmunizatsiya profilaktikasi, homila gemolitik kasalligi, antenatal skrining, intrauterin qon quyish, fototerapiya, almashinuv transfuzion davolash, perinatal natijaAbstract
Ushbu tezisda rezus-immunizatsiya bilan kechuvchi homiladorlikni olib borishda zamonaviy profilaktik va davolash yondashuvlarining samaradorligi tahlil qilindi. Rezus-immunizatsiya homila va yangi tug‘ilgan chaqaloq gemolitik kasalligining asosiy immunologik sabablaridan biri bo‘lib, uning oldini olish va o‘z vaqtida davolash perinatal natijalarni yaxshilashda muhim ahamiyatga ega. Tezisda homiladorlikning erta muddatlarida qon guruhi va rezus omilini aniqlash, antitana skriningi, immunizatsiyalanmagan rezus-manfiy ayollarda anti-D immunoglobulin profilaktikasi, fetomaternal qon aralashuvi bilan bog‘liq xavfli holatlarda maqsadli profilaktika, immunizatsiyalangan homiladorlikda esa antitana titri, fetal antigen statusi, ultratovush va MCA-PSV monitoringi asosida davolash taktikasini tanlash yoritildi. Og‘ir homila anemiyasida intrauterin qon quyish, tug‘ruq muddatini individual belgilash va neonatal davrda fototerapiya, immunoglobulin hamda almashinuv transfuzion davolash samaradorlikka ta’sir etuvchi asosiy yo‘nalishlar sifatida baholandi. Profilaktika va davolashning bosqichma-bosqich algoritmi rezus-immunizatsiya oqibatlarini kamaytirish, homila hayotiyligini saqlash va neonatal asoratlarni cheklash imkonini beradi.References
1. American College of Obstetricians and Gynecologists. Management of Alloimmunization During Pregnancy. ACOG Practice Bulletin No. 192. Obstetrics & Gynecology. 2018
131(3):e82-e90.
2. British Society for Haematology. Guideline for the investigation and management of red cell antibodies in pregnancy. London: BSH
2025.
3. Fung-Kee-Fung K., Armson A., Crane J., et al. Guideline No. 448: Prevention of Rh D Alloimmunization. Journal of Obstetrics and Gynaecology Canada. 2024
46(8):102490.
4. Visser G.H.A., Thommesen T., Di Renzo G.C., et al. FIGO/ICM guidelines for preventing Rhesus disease: A call to action. International Journal of Gynecology & Obstetrics. 2021
152(2):144-147.
5. Moise K.J. Jr., et al. A clinical practice guideline for the management of pregnancy alloimmunized to red blood cell antigens. JAMA Network Open. 2025
8(11):e2544649.
6. Rego S., Ashimi Balogun O., Emanuel K., et al. Cell-free DNA analysis for the determination of fetal red blood cell antigen genotype in individuals with alloimmunized pregnancies. Obstetrics & Gynecology. 2024
144(4):436-443.
7. Benavides-Serralde J.A., et al. Consenso colombiano de diagnostico, prevencion y manejo de la enfermedad hemolitica perinatal. Revista Colombiana de Obstetricia y Ginecologia. 2024
75(3):4142.
8. Valentini B., et al. Red blood cell alloimmunization and pregnancy: Diagnosis and management. Prenatal Diagnosis and Maternal-Fetal Medicine. 2025
1:e70085.